Company page

Amgen Inc.

Amgen Inc. is a leading biotechnology company based in the United States, focused on developing innovative therapies for serious illnesses. With a market capitalization of approximately $197.7 billion, Amgen is recognized for its commitment to advancing science and improving patient outcomes. The company operates in a dynamic market, continually working to address unmet medical needs through its research and development efforts.

AMGN:NASDAQUpdated August 28, 2026
Amgen Inc. logo
Ticker
AMGN:NASDAQ
Asset type
Stock
Market cap
$233.78B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD